Cargando…

Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease

Tumor necrosis factor-α inhibitor (TNF-α) is frequently used for Crohn's disease and other autoimmune conditions. Increased risk of infection is an accepted adverse effect of TNF-α, and routine screening for potential infections are carried out before initiation of therapy. We report the case o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liyanage, I.K., Niriella, M.A., de Silva, A.P., de Silva, N., de Silva, H.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722334/
https://www.ncbi.nlm.nih.gov/pubmed/31616760
http://dx.doi.org/10.14309/crj.0000000000000075
Descripción
Sumario:Tumor necrosis factor-α inhibitor (TNF-α) is frequently used for Crohn's disease and other autoimmune conditions. Increased risk of infection is an accepted adverse effect of TNF-α, and routine screening for potential infections are carried out before initiation of therapy. We report the case of a patient who developed a localized painful swelling near the injection site, which was diagnosed as acute dermato-lymphangio-adenitis due to filarial infection. This adds to the limited number of case reports on parasitic complications following TNF-α therapy.